GlassScriptPhysician profile
Orson W Moe
NPI 1619946191
$21,483.90
in general payments reported to CMS, 2019-2025
7 companies · $937 in 2025
The $937 reported for 2025 was more than what 76% of Nephrology (Internal Medicine) providers received nationally (typical 2025 total: $311).
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,591 · 2020: $6,480 · 2021: $2,390 · 2022: $2,360 · 2023: $595 · 2024: $131 · 2025: $937.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,250 · Travel and Lodging: $160 · Education: $131 · Food and Beverage: $122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,250.00 |
| Travel and Lodging | $160.18 |
| Education | $130.82 |
| Food and Beverage | $122.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $10,480.68 | 2019-2021 | |
| Janssen Research & Development, LLC | $6,480.00 | 2020 | |
| Akebia Therapeutics INC | $2,360.00 | 2022 | |
| Novo Nordisk INC | $1,515.28 | 2023-2025 | Rivfloza |
| Otsuka Pharmaceutical Co., LTD. | $500.00 | 2021 | |
| Idorsia Pharmaceuticals US INC | $130.82 | 2024 | Tryvio |
| Biosense Webster, INC. | $17.12 | 2025 | Nuvision Ice Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Orson Moe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.